MLV


MLV Initiates Coverage On Polypore, Sees 21% Upside For The Stock

In a research note released today, MLV analyst Carter Driscoll initiated coverage on shares of Polypore International (NYSE:PPO) with a Buy rating and …

We Remain Cautious On Clean Energy’s Shares Until We See Faster Adoption, Says MLV

In a research note published today, MLV analyst Carter Driscoll initated coverage on shares of Clean Energy Fuels Corp. (NASDAQ:CLNE) with a Hold …

MLV Reiterates Buy On Peregrine Pharma Following Release Of Preclinical Data On Bavituximab

In a research report released today, MLV analyst George Zavoico reiterated a Buy rating on Peregrine Pharmaceuticals (NASDAQ:PPHM) with a $3.50 price target, …

We Envision Novavax Building A Strong RSV Franchise With Broad Applicability, Says MLV

In a research note issued this morning, MLV analyst George Zavoico reiterated a Buy rating on Novavax (NASDAQ:NVAX) with a $14 price target, …

MLV Maintains Buy On Compugen Following Second Milestone Achievement With Bayer Partnership

In a research note published today, MLV analyst George Zavoico maintained a Buy rating on Compugen (NASDAQ:CGEN) with a $14 price target, following …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts